18 May 2013
Keywords: osi, licenses, its, key, dpp-4, patents, b-ms
Article | 22 December 2006
The USA's OSI Pharmaceuticals says that its diabetes and obesity subsidiary, Prosidion, has granted drug major Bristol-Myers Squibb a
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 December 2006
18 December 2006
17 May 2013
© 2013 thepharmaletter.com